Return to Listing

244 result(s) for Multiple Myeloma

PI Name Protocol # Title
Edward Neuwelt IRB00000922 Phase II Clinical Trial of Patients with High-Grade Glioma Treated with Intra-arterial Carboplatin-based Chemotherapy, Randomized to Treatment with or without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant against Severe Thrombocytopenia
Edward Neuwelt IRB00001012 A Phase II Study of Patients with Newly Diagnosed Primary Central Nervous System Lymphoma Treated with Methotrexate/BBBD, and Adding Rituximab (an anti CD-20 Antibody) and Carboplatin, to the Treatment Regimen
Bonnie Nagel IRB00002560 Neurocognition and Brain Development in Youth (Attention Deficit)
Edward Neuwelt IRB00002868 Phase I/II Study of Carboplatin, Melphalan and Etoposide Phosphate in Conjunction with Osmotic Opening of the Blood-Brain Barrier and Delayed Intravenous Sodium Thiosulfate Chemoprotection, in Previously Treated Subjects with Anaplastic Oligodendroglioma or Oligoastrocytoma
William Rooney IRB00003290 MRI Protocol Development and Optimization
Brett Sheppard IRB00003609 Oregon Pancreas Tissue Registry
Fay Horak IRB00004131 Exercise, Brain Imaging, Cognition, and Gait in Parkinsonism
Cary Harding IRB00004206 Longitudinal Study of Urea Cycle Disorders
Andrew Ahmann IRB00005023 TrialNet Natural History Study of the Development of Type 1 Diabetes
Fay Horak IRB00005029 Development of the Instrumented Test of Mobility (iMOBILITY)
Edward Neuwelt IRB00005056 Phase I/II Study of Intra-arterial Melphalan Given with Intra-arterial Carboplatin, Osmotic Blood-Brain Barrier Disruption and Delayed Otoprotective Sodium Thiosulfate for Patients with Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Kevin Billingsley IRB00005222 Oregon Liver Tumor Registry
Damien Fair IRB00005239 Typical and Atypical Brain Development
Tomasz Beer IRB00005688 A Phase II study of MAOA inhibitor plus docetaxel in patients receiving and progressing on docetaxel therapy
Kelvin MacDonald IRB00005956 Transepithelial Potential Difference Measurements in Patients with Unusual Variants of Cystic Fibrosis
Dennis Crawford IRB00006045 A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee
David Lieberman IRB00006137 VAPORHCS/OHSU J: Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
Kathleen Kemmer IRB00006256 I-SPY 2 TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2
Penelope Hogarth IRB00006459 The Parkinson's Progression Markers Initiative (PPMI)
Curtis Machida IRB00006535 Dominant Mutans Streptococci Genetic Strains in Caries-Active Children
Shoukhrat Mitalipov IRB00006709 [STEM CELLS] Mitochondrial gene replacement in human oocytes
Joel Nigg IRB00006749 Developmental Origins of Attention Deficit Hyperactivity Disorder
Stephen Spurgeon IRB00007195 A Phase II Proof of Concept Trial to Study Kinase Inhibition in Relapsed/Refractory Acute Leukemias: Using a Comprehensive in Vitro Kinase Inhibitor Panel to Select Individualized Targeted Therapies
Robert Peterka IRB00007619 VAPORHCS/OHSU J: Vestibular contribution to the control of human upright stance
Eric Suhler IRB00008634 First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Sonemany Salinthone IRB00008908 VAPORHCS/OHSU J: Elucidating the Mechanisms that Mediate the Effects of Lipoic Acid in Multiple Sclerosis
Fay Horak IRB00008979 VAPORHCS/OHSU J: Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact
David Cohen IRB00009065 Disorders of Water and Electrolyte Balance
Kristen Mackiewicz Seghete IRB00009182 Neural Mechanisms of Cognitive Inhibition in Youth with and without a Trauma History
Tomasz Beer IRB00009204 Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms of Resistance
Christopher Ryan IRB00009241 Randomized, Double-Blind Phase III study of Pazopanib vs Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Joshi Alumkal IRB00009259 Identifying Mechanisms of Resistance to Enzalutamide (MDV3100) Treatment in Men with Castration-Resistant Prostate Cancer
Richard Maziarz IRB00009375 A Phase 1-2 Dose Escalation Study Evaluating Safety and Feasibility of BPX-501 T Cells after Partially Mismatched, Related, T Cell-Depleted HSCT
Emma Scott IRB00009398 A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age
Rodney Pommier IRB00009420 Oregon Index of Endocrine Neoplasias (ORION)
Kevin Winthrop IRB00009463 The Oregon nontuberculous mycobacteria (NTM) cohort; immune correlates of pulmonary NTM disease progression
Christopher Ryan IRB00009464 A Phase II Study of Sorafenib with Chemotherapy, Radiation, and Surgery for High-Risk Soft Tissue Sarcomas
Alfons Krol IRB00009517 A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety, Efficacy, Systemic Exposure, and Pharmacodynamics of Calcipotriene Foam, 0.005%, Versus Vehicle Foam in Pediatric Subjects (Ages 2 to 11 Years) with Plaque Psoriasis
Martin Feeney IRB00009542 VAPORHCS/OHSU J: Community-Based Kiosks for Hearing Screening and Education
Scott Chadderdon IRB00009594 Cardiovascular Inflammation Reduction Trial (CIRT)
Erin Gilbert IRB00009694 The Use of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in the Management of Pancreatic Cancer
Julie Saugstad IRB00009707 Clinical Utility of Extracellular RNA for Biomarker Development (UH2/UH3)
John Morrison IRB00009729 Longitudinal observational study using functional and structural optical coherence tomography to diagnose and guide treatment of glaucoma
Michael Shapiro IRB00009813 International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)
Julie Graff IRB00009892 VAPORHCS/OHSU J: A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Matthew Taylor IRB00009902 A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
Martina Mancini IRB00009903 Characterization and Treatment of Gait Disturbances in Parkinson's disease
Jose Rueda IRB00010059 A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy
Steven Shea IRB00010101 Circadian rhythms and cardiovascular risk
Kevin Winthrop IRB00010178 The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF Users
Eric Fombonne IRB00010207 Preliminary Validity Study of the Continuum of Autism Spectrum Traits (COAST), A Parent Survey of Autistic Behaviors (COAST Study)
Kim-Hien Dao IRB00010262 Prospective Evaluation of ruxolitinib Efficacy for CNL/aCML Patients with Mutation of CSF3R
Lisa Silbert IRB00010264 Protocol H8A-MC-LZAZ(a)/ADC-040-A4 Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4 Study)
Xin Li IRB00010345 Contrast Enhanced MRI of the Prostate
Michael Shapiro IRB00010361 CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia (CASCADE FH Registry)
Stephen Spurgeon IRB00010383 A Phase 1 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-Lag-3 (BMS-986016) in Relapsed or Refractory Chronic Lymphocytic Leukemia and Lymphomas
Kevin Winthrop IRB00010433 A pilot study for the Varicella Zoster Vaccine (VERVE) Trial
Tomasz Beer IRB00010479 A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men with Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
Lara Davis IRB00010529 SARC024: A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing–like sarcomas
Steven Bailey IRB00010535 Optical coherence tomography angiography in neovascular age-related macular degeneration
Michael Heinrich IRB00010537 A Phase I, Multicenter, Open-Label Study of Oral ABL001 in Patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Kimberly Mauer IRB00010548 Functional Imaging of Light-Induced Activation of Pain-Related Circuitry in Fibromyalgia as a Marker for Central Sensitization
Sancy Leachman IRB00010561 War on Melanoma: Enlisting a cohort of melanoma survivors and their families
Cailin Sibley IRB00010580 Risk for Development of ANCA in First-Degree Relatives of Patients with ANCA-Associated Vasculitis
Elie Traer IRB00010674 A Phase 3 Open-Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed after First-Line Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
Mary Samuels IRB00010709 OCTRI Research Volunteer Registry
John Nutt IRB00010745 Effects of augmenting cholinergic function on gait and balance
Patricia Carlson-Kuhta IRB00010775 Monitoring Balance and Gait Disorders in Parkinson’s Disease with the Home Objective Mobilty Exam (HOME)
Anna Wilson IRB00010782 Maternal Chronic Pain
Michael Heinrich IRB00010886 A companion sample collection protocol to support the discovery of the mechanisms of resistance to targeted cancer therapies.
Thomas Hwang IRB00010949 Functional Optical Coherence Tomography-Derived Biomarkers for Diabetic Retinopathy
John Hunter IRB00010973 Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry (STAR registry)
Julie Graff IRB00011025 Addition of Pembrolizumab Upon Progression on Enzalutamide in men with mCRPC
Jeremy Cetnar IRB00011046 [NCI CIRB]S1400: Lung-MAP, Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
Charles Henrikson IRB00011084 Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
Emma Scott IRB00011097 A Feasibility Study of Myeloablative BEAM Allogeneic Transplantation Followed by Oral Ixazomib Maintenance Therapy in Patients with Relapsed High-Risk Multiple Myeloma
Bart Moulton IRB00011150 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract
Bart Moulton IRB00011151 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial Virus (RSV) Infection of the Upper Respiratory Tract
Daniel Herzig IRB00011161 A Phase II Multicenter Randomized Trial Evaluating 3-Year Disease-Free Survival in Patients with Locally Advanced Rectal Cancer Treated with Chemoradiation Plus Induction or Consolidation Chemotherapy, and Total Mesorectal Excision or Non-Operative Management
Wayne Clark IRB00011170 VAPORHCS/OHSU J: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (VA/OHSU (J): CREST-2)
Nicole Marshall IRB00011175 Maternal Body Composition Regulates Placental Function and Fetal Growth
Lynne Morrison IRB00011208 A Randomized, Double-Blind, Double-Dummy, Active-Comparator, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab Versus MMF in Patients With Pemphigus Vulgaris
Julie Graff IRB00011227 VAPORHCS/OHSU J: A Phase I/II Trial of Concurrent Chemohormonal Therapy Using Enzalutamide (MDV-3100) and Cabazitaxel in Patients with Metastatic Castration Resistant Prostate Cancer
Larisa Tereshchenko IRB00011299 Adaptive CRT effect on ELectrical dysSYNChrony (aCRT ELSYNC)
Stephen Spurgeon IRB00011311 A Phase 1/2 Proof-of-concept study of the combination of ACP-196 and ACP-319 in subjects with B-cell malignancies
Charles Henrikson IRB00011312 World-wide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT)
Kathleen Kemmer IRB00011351 A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
Helmi Lutsep IRB00011352 Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients with a recent Embolic Stroke of Undetermined Source (ESUS), comparing rivaroxaban 15 mg once daily with aspirin 100 mg (NAVIGATE ESUS)
Khaled Tolba IRB00011462 A Randomized, Open-Label, Phase I Trial of Continuous, Intermittent, and Pulsatile Selumetinib (AZD6244) plus Paclitaxel as Second-Line Treatment for Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Kevin Winthrop IRB00011471 A Randomized, Open-Label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients with Nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium avium complex (MAC) that are refractory to treatment
Sarah Feldstein Ewing IRB00011481 Motivational Interviewing and Neuroimaging with Adolescents (MINA)
Henry Milczuk IRB00011538 Developing a National Registry for JORRP (Juvenile Onset Recurrent Respiratory Papillomatosis)
Jeffrey Kaye IRB00011606 Alzheimer's Comprehensive Treatment Network of Oregon and Washington (ACTNOW!)
Matthew Taylor IRB00011638 A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Head and Neck Squamous Cell Carcinoma
Matthew Taylor IRB00011688 A Phase 1 Study of the Oral TRK Inhibitor LOXO-101 in Adult Patients with Solid Tumors
Gina Vaccaro IRB00011746 I4T-MC-JVDE: Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (AFP) Following First-Line Therapy With Sorafenib
Stephen Spurgeon IRB00011766 A Phase Ib Feasibility Study of Personalized Kinase Inhibitor Therapy Combined with Induction Chemotherapy in Acute Myeloid Leukemia in Patients who Exhibit in vitro Kinase Inhibitor Sensitivity
Alison Edelman IRB00011784 Determining the impact of combined hormonal contraceptives on ulipristal acetate
Nir Modiano IRB00011801 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
Michelle Cameron IRB00011805 PVAMC / OHSU J: Comprehensive Fall Prevention and Detection in MS
Jeremy Cetnar IRB00011845 A Phase III, Open-Label, Multicenter, Randomized Study of Atezolizumab (Anti-PD-LI Antibody) Compared with A Platinum Agent (Cisplatin or Carboplatin) in Combination with either Pemetrexed or Gemcitabine for PD-L1-Selected, Chemotherapy-Naïve Patients Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
Barry Oken IRB00011847 Meditation or Health & Wellness Education via Internet for Adults 50-80 Years Old
Brandon Hayes-Lattin IRB00011894 Protocol CCTL019B2206: A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial
Weronika Crescini IRB00011949 The Efficacy and Safety of Acute Normovolemic Hemodilution in Pediatric Cardiac Surgery Patients
Brandon Hayes-Lattin IRB00011960 Long Term Follow-Up of Patients Exposed to Lentiviral- Based CD19 directed CART Cell Therapy
Miriam Treggiari IRB00011975 Factor VIII Inhibitor Bypass Activity (FEIBA) for the Reduction of Transfusion in Cardiac Surgery: A Randomized Double Blind Placebo Controlled Pilot Trial
Matthew Taylor IRB00012008 CPDR001X2101: Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001 Administered to Patients with Advanced Malignancies
Khaled Tolba IRB00012012 A Phase III, Open-Label, Randomized Study To Investigate The Efficacy And Safety Of MPDL3280A (ANTI−PD-L1 ANTIBODY) Compared With Best Supportive Care Following adjuvant Cisplatin-Based Chemotherapy In PD-L1−Selected Patients With Completely Resected STAGE IB−IIIA
Emma Scott IRB00012018 A Phase 3, Randomized, Multicenter, Double-Blind Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care vs Placebo Plus Standard of Care in Subjects with Light Chain (AL) Amyloidosis
Stephen Heitner IRB00012026 [MOU-Vanderbilt-IRBShare] Exercise in Genetic Cardiovascular Conditions
Lara Davis IRB00012039 Sarcoma Survivorship Registry
Michael Heinrich IRB00012061 A Phase 1 Study of BLU-285 in Patients with Gastrointestinal Stromal Tumors (GIST) and other Relapsed and Refractory Solid Tumors
Alexandra Dimitrova STUDY00015004 AMES+tDCS brain stimulation
Jacqueline Vuky STUDY00015006 A Phase III, Double-Blind Placebo-Controlled, Randomized Study of Taselisib plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive and HER2-Negative Locally Advanced or Metastatic Breast Cancer who have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy.
Laurie King STUDY00015010 PVAMC/OHSU J: Rehabilitation of Central Sensory Impairments for Balance in mTBI
Barry Schlansky STUDY00015047 A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis (NASH) 747-303
Larisa Tereshchenko STUDY00015049 Pilot observational case-control study of the electrical heterogeneity in patients with hypertrophic cardiomyopathy and high arrhythmic-risk
MinKyoung Song STUDY00015075 Healthy Parents, Healthy Families
Michael Heinrich STUDY00015085 A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients with Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Hormozd Bozorgchami STUDY00015098 A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study to Evaluate the Effects of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Damien Fair STUDY00015099 Early Neurobiological Predictors of Executive Functioning in Toddlers
Alexey Danilov STUDY00015136 A Phase 1B Dose Escalation and Dose Expansion Study of ONO/GS-4059 in Combination with Other Targeted Anti-cancer Therapies in Subjects with B-cell Malignancies
Steven Shea STUDY00015145 Sleep, inactivity, circadian rhythms and cardiovascular risk
Arpana Naik STUDY00015164 A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Kathleen Kemmer STUDY00015176 A Randomized Open-Label Phase 3 Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician's Choice for Metastatic Triple Negative Breast Cancer (mTNBC)
Antonio Frias STUDY00015196 Functional imaging of human placenta by MRI
Matthew Taylor STUDY00015206 An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
Emma Scott STUDY00015214 A Phase 1a/1b, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies
Frederick Gallun STUDY00015217 VAPORHCS/OHSU J: Efficient diagnostic tools to evaluate central auditory dysfunction
Jeremy Cetnar STUDY00015218 A Phase 3 Prospective, Randomized, Double-Blind, Multi-Center, Study Of The Efficacy And Safety Of Lanreotide Autogel/ Depot 120mg Plus BSC Vs Placebo Plus BSC For Tumor Control In Subjects With Well-Differentiated, Metastatic And/Or Unresectable Typical Or Atypical Lung Neuroendocrine Tumors
Eric Simpson STUDY00015223 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-Resistant Pruritus Associated with Atopic Dermatitis
Jeremy Cetnar STUDY00015245 S1314: A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
Stephen Spurgeon STUDY00015255 IIT: A Phase II study of Obinutuzumab (GA-101) in Combination with Ibrutinib (I) for the Treatment of Relapsed Mantle Cell Lymphoma (ML29535)
Arthur Hung STUDY00015290 A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment with Primary Radiation Therapy
Matthew Taylor STUDY00015298 [NCI CIRB] EA6134: A Randomized Phase III trial of Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant Melanoma
Charles Lopez STUDY00015304 CC #144525: Study of the Safety, Immunopharmacodynamics and Anti-tumor Activity of Ibrutinib Combined with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma
Craig Okada STUDY00015315 Phase 1/2 Study of Intratumoral G100 With or Without Pembrolizumab in Patients with Follicular Non-Hodgkin's Lymphoma
Melanie Fried-Oken STUDY00015331 Clinic Interactions of a Brain-Computer Interface for Communication
Dennis Crawford STUDY00015353 Prospective, Multi-Center, Single-Arm, Pilot Study to Evaluate Symptom Relief in Subjects with Medial Knee Osteoarthritis Treated with the Atlas™ Knee System for Load Reduction.
Kim-Hien Dao STUDY00015363 WEAR in Oregon: Defining risks of blood cancer development in a cohort of older women with clonal hematopoiesis and TET2 mutations. (Women Engaged in Advancing health Research in Oregon is a prospective epidemiology study)
Kathleen Kemmer STUDY00015366 ONT-380-206: Phase 2 Randomized, Double-Blinded, Controlled Study of tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Richard Maziarz STUDY00015386 Prospective, phase II/III, randomized clinical study to compare BEGEDINA versus "conventional treatment" for treating steroid resistant acute graft-versus-host disease
Patricia Norris STUDY00015410 Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study
Kathryn Holmes STUDY00015426 Effectiveness of Fetal Counseling in Congenital Heart Disease
Gina Vaccaro STUDY00015439 A Phase III Randomized Open-label Study of Single Agent Pembrolizumab vs Physicians' Choice of Single Agent Docetaxel, Paclitaxel, or Irinotecan in Subjects with Advanced/Metastatic Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus that have Progressed after First-Line Standard Therapy (KEYNOTE-181)
Richard Maziarz STUDY00015460 Allogeneic Stem Cell Transplantation of NiCord, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells, in Adolescent and Adult Patients with Hematological Malignancies
Rachel Cook STUDY00015467 SWOG S0919: A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Poor-Risk Acute Myelogenous Leukemia (AML)
Joseph Quinn STUDY00015474 A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Amie Hiller STUDY00015494 (MOU NeuroNEXT NN105) An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects with Huntington's Disease (HD)
Gina Vaccaro STUDY00015495 A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177)
Karen Lyons STUDY00015498 Together: A Pilot Study of Young and Middle-Aged Couples with Cancer in Rural and Urban Areas
Tomasz Beer STUDY00015561 A Phase Ib/II, Multicentre, Open Label, Randomised Study of BI 836845 in Combination with Enzalutamide, versus Enzalutamide alone, in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Following Disease Progression on Docetaxel-Based Chemotherapy and Abiraterone. Protocol 1280.8
Fay Horak STUDY00015568 Fatigue in Multiple Sclerosis
Matthew Taylor STUDY00015572 An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)
Michael Heinrich STUDY00015581 A Phase 1, Open-label, Dose-escalation and Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KTN0158 in Adult Patients with KIT Positive Advanced Solid Tumors
Eric Fombonne STUDY00015593 Oregon SPARK: National Autism Cohort 50k
Michelle Cameron STUDY00015595 VAPORHCS/OHSU J: Evaluation of a web-based fall prevention program in people with multiple sclerosis
Jeremy Cetnar STUDY00015597 A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versusPlacebo in Subjects with High Risk Invasive Urothelial Carcinoma
Marcel Curlin STUDY00015598 CMV seroprevalence and feasibility of CMV-vectored prophylactic immunization trial
Elie Traer STUDY00015601 A Phase 1, Multi-center, Open-label Study of IMGN779 Administered Intravenously in Adult Patients with Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Eva Medvedova STUDY00015608 Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Joshi Alumkal STUDY00015617 Phase 1 Safety and Tolerability Study of ZEN003694 as a Single Agent in Patients with Metastatic Castration-resistant Prostate Cancer (ZEN003694-001)
Laura Newell STUDY00015619 A phase 1/2 study of Vadastuximab Talirine (SGN-CD33A) in combination with Azacitidine in patients with previously untreated international prognostic scoring system (IPSS) intermediate -2 or high-risk Myelodysplastic Syndrome (MDS).
Matthew Taylor STUDY00015661 [NCI CIRB] S1404: A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma
Jeremy Cetnar STUDY00015662 CA209-451: A Randomized, Multicenter, Double Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (SCLC) after Completion of Platinum-based First Line Chemotherapy
Matthew Taylor STUDY00015678 A Phase 1a/1b Study of FPA008 in Combination with Nivolumab in Patients with Selected Advanced Cancers
Alexey Danilov STUDY00015680 A Phase Ib/II, Open label, Single Arm, Multi-center, Dose Escalation Trial of Intravenous BI 836826 in Combination with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Aaron Ziegler STUDY00015683 Vocal Dose and Physical Fitness Profiles of Older Adults With and Without Age-related Voice Problems
Allison Lindauer STUDY00015695 STAR-C-Telemedicine: Accessible Caregiver Support
Brett Sheppard STUDY00015705 The OHSU Pancreas Community Registry
Gina Vaccaro STUDY00015706 EMR100070-007: A Phase III open-label, multicenter trial of maintenance therapy with avelumab (MSB0010718C) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic, adenocarcinoma of the stomach, or of the gastro-esophageal junction
Matthew Taylor STUDY00015716 A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors
Miriam Treggiari STUDY00015721 A multicenter, randomized, double-blind, placebo-controlled, adaptive design study evaluating the analgesic efficacy and safety of intravenous CR845 in patient undergoing abdominal surgery
Tanja Pejovic STUDY00015737 (ONC-DPX-Survivac-06): A Phase 1b Study of an Immunotherapeutic Vaccine, DPX-Survivac with Low Dose Cyclophosphamide and Epacadostat (INCB024360) in Patients with Recurrent Ovarian Cancer
Alexey Danilov STUDY00015747 A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with TGR-1202 Compared to Obinutuzumab in Combination with Chlorambucil in Patients with Chronic Lymphocytic Leukemia (CLL)
Matthew Taylor STUDY00015752 A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination with Epacadostat in Adults with Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer
Chafic Karam STUDY00015773 Cross-Sectional ALS Biofluid Biomarker (CABB) Study
Fay Horak STUDY00015780 Relationships Between Fatigue, Mobility, Histidine, and Proinflammatory Cytokines in Multiple Sclerosis
Firas Zahr STUDY00015782 Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Stephen Heitner STUDY00015807 A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects with Light Chain (AL) Amyloidosis who have Persistent Cardiac Dysfunction
Jeremy Cetnar STUDY00015834 A Phase 1 Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination with Tremelimumab (Anti-CTLA-4 Antibody) in Subjects with Advanced Solid Tumors
Andy Chen STUDY00015836 A Phase 1/2, Open-Label, Uncontrolled, Multiple-Dose Escalation, Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ASN002 in Relapsed/Refractory Lymphoma and Advanced Solid Tumors
Jennifer Barton STUDY00015851 VAPORHCS/OHSU J: Goal concordance in rheumatoid arthritis: a survey study
Emma Scott STUDY00015863 A Phase 1/2 Open label trial of SL-401 in combination with Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
Stephen Heitner STUDY00015877 A Phase 2, Multi-Center, Open-Label, Ascending Dose Study on the Efficacy, Safety and Tolerability of Perhexiline in Patients with Hypertrophic Cardiomyopathy and Moderate-to Severe Heart Failure with Preserved Left Ventricular Function
Jeffrey Jensen STUDY00015881 Tamoxifen to reduce unscheduled bleeding in new users of the Levonorgestrel-releasing intrauterine system (LNG-IUS)
Rachel Cook STUDY00015903 A Randomized, Phase II Study of CX-01 Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia
Matthew Taylor STUDY00015911 A Phase 1b Open-Label Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined with Pembrolizumab in Subjects with Selected Hyaluronan-High Solid Tumors
Kerri Winters STUDY00015921 INTense Exercise foR surVivAL among men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-MCRPC): A Multicenter, Randomized, Controlled, Phase III Study
Matthew Taylor STUDY00015941 A Phase 1b/2, Open-label, Dose Escalation Study of Entinostat in Combination with Pembrolizumab in Patients with Non-small Cell Lung Cancer, with Expansion Cohorts in Patients with Non-small Cell Lung Cancer and Melanoma
Erika Cottrell STUDY00015946 Health Experiences Research Initiative - Pediatric Oncology
Rachel Cook STUDY00015953 A Biomarker-Directed Phase 2 Trial of SY-1425, a Selective Retinoic Acid Receptor Alpha Agonist, in Adult Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Maureen Baldwin STUDY00015974 Feasibility of Medical Abortion by direct-to-consumer telemedicine
Kim-Hien Dao STUDY00015977 [NCI CIRB] The National Myelodysplastic Syndromes (MDS) Study
Lara Davis STUDY00015989 A PHASE 2-3, MULTICENTER, RANDOMIZED, DOUBLE BLIND STUDY OF SELINEXOR (KPT-330) VERSUS PLACEBO IN PATIENTS WITH ADVANCED UNRESECTABLE DEDIFFERENTIATED LIPOSARCOMA (DDLS)
Matthew Taylor STUDY00016017 An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors
Lara Davis STUDY00016039 [NCI CIRB] A Phase 2 Study of GPNMB-targeted Antibody-Drug Conjugate, CDX-011 (Glembatumumab Vedotin, CR011-vcMMAE; IND# 128248, NSC# 763737), in Recurrent or Refractory Osteosarcoma
Gina Vaccaro STUDY00016058 CA209-577: A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer (CheckMate 577: CHECKpoint pathway and nivoluMab clinical Trial Evaluation 577)
Chafic Karam STUDY00016065 Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Lara Davis STUDY00016070 A Phase 1B Study of Ribociclib in Combination with Doxorubicin in Advanced Soft Tissue Sarcomas
Christopher Ryan STUDY00016085 A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)
Julie Graff STUDY00016093 A Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated with Chemotherapy (KEYNOTE-199)
Alexander Guimaraes STUDY00016101 Novel Imaging of Lymph Nodes in Patients with Rectal Cancer Using Ferumoxytol Enhanced MRI
Alexandra Dimitrova STUDY00016105 Nerve-Specific Local and Systemic Analgesic Effects of Acupuncture in Healthy Adults, Measured by Quantitative Sensory Testing (QST)
Raymond Bergan STUDY00016113 Molecular Mechanisms of Tumor Evolution and Resistance to Therapy
Gina Vaccaro STUDY00016133 A Phase III Study of Pembrolizumab (MK-3475) vs. Best Supportive Care as Second-Line Therapy in Subjects with Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-240)
Stephen Heitner STUDY00016139 A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction (Pioneer-HCM)
Elie Traer STUDY00016142 A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation
Lara Davis STUDY00016146 Randomized Phase IIb Trial of Vigil™ (bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) versus gemcitabine + docetaxel for Ewing’s Sarcoma
Curtis Billings STUDY00016148 VAPORHCS/OHSU J: The brain-behavior relationship: age, hearing, and their effects on understanding speech in noise
Alison Skalet STUDY00016162 A Phase 1, Open-label, Multicenter Study Evaluating the Safety and Tolerability, Biologic Activity, Pharmacodynamics, and Pharmacokinetics of Single and Repeated Escalating Intravitreal Doses of ICON-1 in Patients with Uveal Melanoma Who are planned to Undergo Enucleation or Brachytherapy
Richard Maziarz STUDY00016189 A Phase 1 Non-Randomized, Open-Label/Phase 2 Randomized, Blinded Study of ProTmune (ex vivo Programmed Mobilized Peripheral Blood Cells) Versus Non-Programmed Mobilized Peripheral Blood Cells for Allogeneic Hematopoietic Cell Transplantation in Adult Subjects with Hematologic Malignancies
Matthew Taylor STUDY00016198 A Phase 1 Dose Escalation Trial of Intratumoral Injections of TTI-621 in Subjects with Relapsed and Refractory Percutaneously-Accessible Solid Tumors and Mycosis Fungoides
Matthew Taylor STUDY00016225 IMCgp100-201: A Phase Ib/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 in Combination with Durvalumab (MEDI4736) or Tremelimumab or the Combination of Durvalumab and Tremelimumab Compared to IMCgp100 Alone in Patients with Advanced Melanoma
Miriam Treggiari STUDY00016228 Randomized Trial of Early Hemodynamic Management of Patients following Acute Spinal Cord Injury (TEMPLE)
Khaled Tolba STUDY00016230 A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination with Ipilimumab versus Nivolumab in combination with Ipilimumab placebo Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Dennis Crawford STUDY00016254 A Phase 3 Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D, Compared to Microfracture in the Treatment of Articular Cartilage Defects
Gina Vaccaro STUDY00016255 INCB 54828-202: A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy
Jeremy Cetnar STUDY00016256 TO-TAS-114-201: A Randomized, Open-Label, Multi-Center, International Phase 2 Study of TAS-114 in Combination with S-1 in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
Lisa Silbert STUDY00016260 Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3)
James Mudd STUDY00016277 EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Alison Edelman STUDY00016291 Improving the effectiveness of orally-dosed emergency contraceptives in obese women
Christopher Ryan STUDY00016300 A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-426)
Khaled Tolba STUDY00016349 [Quorum] CINC280A2201: A phase II, multicenter, four-cohort study of oral cMET inhibitor INC280 in adult patients with EGFR wild-type (wt), advanced non-small cell lung cancer (NSCLC) who have received one or two prior lines of systemic therapy for advanced/metastatic disease
Brandon Togioka STUDY00016351 An assessor-blinded, randomized, controlled, single center, parallel design trial to compare the incidence of postoperative pulmonary complications (PPCs) associated with rocuronium neuromuscular reversal with Sugammadex versus Neostigmine in patients 70 years of age or older undergoing surgery of at least 3 hours (SugPPC)
Kim-Hien Dao STUDY00016363 A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
Michael Heinrich STUDY00016365 CrenoGIST– A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene
Arthur Hung STUDY00016373 A Pilot Study Investigating 18F-FLT-PET as a Marker of Response to Preoperative Radiotherapy in Soft Tissue Sarcoma
Jeremy Cetnar STUDY00016393 A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations
Frederick Tibayan STUDY00016427 Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3
Rachel Cook STUDY00016429 A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the FLT3 Inhibitor Gilteritinib (ASP2215) Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects with FLT3/ITD AML in First Complete Remission
Jeffrey Jensen STUDY00016434 A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone
Uma Borate STUDY00016475 A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)
Alison Edelman STUDY00016519 Treatment of unfavorable bleeding patterns in contraceptive implant users
Bonnie Nagel STUDY00016521 Neurocircuitry of acute alcohol intoxication in individuals at familial history risk for alcoholism
MinKyoung Song STUDY00016536 Healthy Grandparents, Healthy Grandkids
Aaron Ziegler STUDY00016619 Epidemiology of Vocal Health in Dysphonic Patients Using Marijuana: A Multicenter Survey Study
Amira Al-Uzri STUDY00016623 Pharmacokinetics of Anti-epileptic Drugs in Obese Children
Jeffrey Jensen STUDY00016633 Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-releasing Intrauterine System) for Long-Acting Reversible Contraception
Jeffrey Jensen STUDY00016655 Multi-center, open-label, uncontrolled study to assess contraceptive efficacy and safety of Mirena during extended use beyond 5 years in women 18 to 35 years of age including a subgroup evaluation of treatment effect on heavy menstrual bleeding.
Joseph El Youssef STUDY00016761 Evaluating the dynamics of insulin and non-insulin mediated effects on glucose during aerobic exercise in subjects with type 1 diabetes.
Myriam Loyo STUDY00016776 Exploratory Study of the Central Nervous System Response in Facial Synkinesis after Bell's palsy
Andy Chen STUDY00016830 [NCI CIRB] A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Amy Holley STUDY00016872 Light Sensitivity in Pediatric Musculoskeletal Pain
 

You may also qualify for Phase 1 Program trials.

 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080